Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics
15 août 2022 23h41 HE
|
Endure Biotherapeutics, Inc.
San Diego, Aug. 15, 2022 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Endure Biotherapeutics, Inc. Announces Publication of Founder’s Seminal Work Regarding Colonizing Biotherapeutics Zarrinpar...
The live biotherapeutic products and microbiome manufacturing market is projected to grow at a CAGR of 20% during 2022-2035, claims Roots Analysis
06 avr. 2022 13h14 HE
|
Roots Analysis
London, April 06, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Live Biotherapeutic Products and Microbiome Manufacturing Market, 2022–2035” report to its list of...
Final Results for the year ended 31 December 2020
01 avr. 2021 07h00 HE
|
4D Pharma PLC
Leeds, UK, April 01, 2021 (GLOBE NEWSWIRE) -- 4D pharma plc (AIM: DDDD, NASDAQ: LBPS) (“4D”, the “Company” or, together with its subsidiaries, the “Group”), a pharmaceutical company leading the...